|
UTHR | United Therapeutics Corp |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.28 |
| Leverage | 10.35% |
| Market Cap | $ 23.2B |
| PE | 18.33 |
| Dividend Yield | 0.00% |
| Profit | $ 1.3B |
| Margin | 40.66% |
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.